Skin microbiota and diabetic foot ulcers

Area of Science:

• Microbiology
• Dermatology
• Genomics

Background:

• The skin microbiota, a symbiotic microbial community, is crucial for skin health and immune regulation.
• Imbalances in skin microbiota are observed in diabetic foot ulcers (DFUs), characterized by increased pathogenic bacteria like Staphylococcus aureus and Pseudomonas aeruginosa.
• These microbial shifts contribute to biofilm formation, skin barrier disruption, and impaired wound healing in DFUs.

Purpose of the Study:

• To investigate the role of skin microbiota dysbiosis in the pathogenesis and healing of diabetic foot ulcers.
• To explore the potential of modulating skin microbiota composition as a therapeutic strategy for improving DFU outcomes.
• To highlight current research advancements and future directions in understanding the skin microbiome in DFUs.

Main Methods:

• Utilized 16S rRNA gene sequencing to analyze the composition of skin microbiota in DFU patients.
• Reviewed existing literature on the correlation between skin microbiota diversity and DFU severity.
• Examined emerging therapeutic approaches targeting the skin microbiome for DFU treatment.

Main Results:

• Skin microbiota diversity is positively correlated with DFU severity.
• Increased abundance of pathogenic bacteria (e.g., Staphylococcus aureus, Pseudomonas aeruginosa) and biofilm formation are key features of DFUs.
• Modulating the skin microbiota composition shows promise for enhancing DFU healing.

Conclusions:

• Skin microbiota dysbiosis is a significant factor in diabetic foot ulcer development and poor healing.
• Targeting the skin microbiome through interventions like probiotics or personalized regimens represents a promising therapeutic avenue for DFUs.
• Further research is needed to fully elucidate the complex interactions within the skin microbiome and its impact on DFU prognosis, including the role of fungi and viruses.